This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. COBRE Core C Has under the guidance of Dr?s Hatton and Von Bartheld established and equipped a ?state of the art? imaging facility within the School of Medicine at the University of Nevada, Reno. The capabilities of this facility include a wide variety of light microscopical equipment and techniques to fluorescent and laser scanning confocal microscopy techniques. The Imaging and Morphology Core supports the COBRE projects with their needs for protein localization, imaging, quantification of histological lesions using recently developed image analysis software, antibody design, testing and production. In addition, the Core supports research efforts in stereological quantification calibration and improvement of existing techniques. As the specific aims of several of the COBRE projects have been modified or expanded, the Imaging Core will adapt to meet the new needs. Specifically, this will involve examination of transgenic animals, the design and development of new antibodies and the expansion of the facilities capabilities to carry out FRET analysis and the monitoring of chloride ion movements at the cellular and subcellular levels. It is envisaged that a further and better understanding of the roles and regulation of such ion channels in the heart will help illucidate potential tools for the therapeutic intervention in human cardiac disease and dysfunction.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
5P20RR015581-07
Application #
7381167
Study Section
Special Emphasis Panel (ZRR1-RI-8 (01))
Project Start
2006-06-01
Project End
2007-05-31
Budget Start
2006-06-01
Budget End
2007-05-31
Support Year
7
Fiscal Year
2006
Total Cost
$218,102
Indirect Cost
Name
University of Nevada Reno
Department
Pharmacology
Type
Schools of Medicine
DUNS #
146515460
City
Reno
State
NV
Country
United States
Zip Code
89557
Ba, Mariam A; Surina, Jeffrey; Singer, Cherie A et al. (2017) Knockdown of subunit 3 of the COP9 signalosome inhibits C2C12 myoblast differentiation via NF-KappaB signaling pathway. BMC Pharmacol Toxicol 18:47
Duan, Dayue Darrel (2013) Phenomics of cardiac chloride channels. Compr Physiol 3:667-92
Forrest, Abigail S; Joyce, Talia C; Huebner, Marissa L et al. (2012) Increased TMEM16A-encoded calcium-activated chloride channel activity is associated with pulmonary hypertension. Am J Physiol Cell Physiol 303:C1229-43
von Bartheld, Christopher S (2012) Distribution of Particles in the Z-axis of Tissue Sections: Relevance for Counting Methods. Neuroquantology 10:66-75
Angermann, Jeff E; Forrest, Abigail S; Greenwood, Iain A et al. (2012) Activation of Ca2+-activated Cl- channels by store-operated Ca2+ entry in arterial smooth muscle cells does not require reverse-mode Na+/Ca2+ exchange. Can J Physiol Pharmacol 90:903-21
Li, Chuanwei; Pei, Fang; Zhu, Xiaoshan et al. (2012) Circulating microRNAs as novel and sensitive biomarkers of acute myocardial Infarction. Clin Biochem 45:727-32
Wiggins, Larisa M; Kuta, A; Stevens, James C et al. (2012) A novel phenotype for the dynein heavy chain mutation Loa: altered dendritic morphology, organelle density, and reduced numbers of trigeminal motoneurons. J Comp Neurol 520:2757-73
Duan, Dayue Darrel (2011) The ClC-3 chloride channels in cardiovascular disease. Acta Pharmacol Sin 32:675-84
He, Xuyu; Gao, Xiuren; Peng, Longyun et al. (2011) Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7. Circ Res 108:164-75
Xiang, Sunny Yang; Ye, Linda L; Duan, Li-lu Marie et al. (2011) Characterization of a critical role for CFTR chloride channels in cardioprotection against ischemia/reperfusion injury. Acta Pharmacol Sin 32:824-33

Showing the most recent 10 out of 77 publications